טוען...

A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome

This prospective observational study evaluated the efficacy and safety of long-term decitabine treatment in patients with myelodysplastic syndrome (MDS). Decitabine 20 mg/m(2)/day was administered intravenously for 5 consecutive days every 4 weeks to MDS patients in intermediate-1 or higher Internat...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Oncotarget
Main Authors: Jeong, Seong Hyun, Kim, Yoo-Jin, Lee, Je-Hwan, Kim, Yeo-Kyeoung, Kim, Soo Jeong, Park, Sung Kyu, Do, Young Rok, Kim, Inho, Mun, Yeung-Chul, Kim, Hoon Gu, Lee, Won Sik, Yi, Hyeon Gyu, Joo, Young-Don, Choi, Chul Won, Kim, Suk Ran, Na, Sang Min, Jang, Jun Ho
פורמט: Artigo
שפה:Inglês
יצא לאור: Impact Journals LLC 2015
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4792606/
https://ncbi.nlm.nih.gov/pubmed/26517692
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!